Soleno Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$41.42(as of Jan 13, 3:37 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Soleno Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$41.42
Ticker SymbolSLNO
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees152
CountyUSA
Market Cap$2,309.5M

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.

Soleno Therapeutics Inc In Our Stock Scanner

As of Jan 13, 2026
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
example chart graphic
Scan Name: 52-Week LowScan Type: Stock Fundamentals
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.